semaglutide oral or injection ACC 2025: Reduces Cardiovascular Events by 14% at 4 Years Comparing Oral and Injectable Forms

Researchers chose people living with HIV because the infection is associated with accelerated biological aging

Oral semaglutide (Novo Norilsk), on the other hand, was designed to survive the digestive system

No surprise bills

11 Although not a T2D trial, SELECT (semaglutide) enrolled patients with overweight or obesity (BMI 27 kg/m 2 ) and established CVD

The longest and largest trial of GLP-1 receptor agonists in patients with atherosclerotic cardiovascular disease has demonstrated that semaglutide results in improved cardiovascular outcomes independent of baseline adiposity and over a wide range of treatment-induced weight loss

That would narrow the gap with retatrutide substantially